Andrew and Nicola Forrest's Mindaroo an investor in COVID nasal spray developed by Hunter researcher Nathan Bartlett

Anita Beaumont
Updated June 18 2021 - 5:55pm, first published 4:30pm
Hope: Hunter researcher Nathan Bartlett led studies into a nasal spray treatment that could prevent COVID-19. The project has secured $32 million to start human clinical trials. Picture: Jonathan Carroll
Hope: Hunter researcher Nathan Bartlett led studies into a nasal spray treatment that could prevent COVID-19. The project has secured $32 million to start human clinical trials. Picture: Jonathan Carroll

A NASAL spray that could help prevent COVID-19 and the common cold is one step closer to hitting the market after a $32 million investment from the likes of Andrew "Twiggy" Forrest.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Anita Beaumont

Anita Beaumont

Journalist

Anita Beaumont is a health and general news reporter at the Newcastle Herald.

Get the latest Tamworth news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.